These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35194221)

  • 1. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Jiang X; Zhou X; Yu X; Chen X; Hu X; Lu J; Zhao H; Cao Q; Gu Y; Yang Y; Jiang W; Jin M
    Mod Pathol; 2022 Jul; 35(7):929-937. PubMed ID: 35194221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of PD-L1 expression with CD8+ T cells and oxidative stress-related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma.
    Zhang X; Yang Y; Zhao H; Tian Z; Cao Q; Li Y; Gu Y; Song Q; Hu X; Jin M; Jiang X
    J Pathol Clin Res; 2024 Jul; 10(4):e12390. PubMed ID: 38992928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
    Gao Y; Li M; Wang B; Ma Y
    Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
    Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
    J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
    Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X
    Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern.
    Xue Z; Nuerrula Y; Sitiwaerdi Y; Eli M
    Biomol Biomed; 2024 May; 24(3):545-559. PubMed ID: 38340316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.
    Cui Y; Chen H; Xi R; Cui H; Zhao Y; Xu E; Yan T; Lu X; Huang F; Kong P; Li Y; Zhu X; Wang J; Zhu W; Wang J; Ma Y; Zhou Y; Guo S; Zhang L; Liu Y; Wang B; Xi Y; Sun R; Yu X; Zhai Y; Wang F; Yang J; Yang B; Cheng C; Liu J; Song B; Li H; Wang Y; Zhang Y; Cheng X; Zhan Q; Li Y; Liu Z
    Cell Res; 2020 Oct; 30(10):902-913. PubMed ID: 32398863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2.
    Han M; Li N; Li F; Wang H; Ma L
    Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
    Wang Z; Zhang J; Li M; Kong L; Yu J
    Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p62 and/or NFE2L2 induced autophagy impaires esophageal squamous cell cancer metastasis by reversing EMT.
    Chen X; Yu L; Zhou J; Ren J; Wang S; Tan Y; Ding Y
    Gene; 2023 Mar; 858():147194. PubMed ID: 36641074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
    Gao Y; Wan L; Li M; Wang B; Ma Y
    Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma.
    Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A
    Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
    He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K
    Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis.
    Xiao S; Liu N; Yang X; Ji G; Li M
    Free Radic Biol Med; 2021 Feb; 164():58-75. PubMed ID: 33307164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.
    Han N; Zhang YY; Zhang ZM; Zhang F; Zeng TY; Zhang YB; Zhao WC
    Medicine (Baltimore); 2021 May; 100(20):e25932. PubMed ID: 34011067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
    Beinse G; Just PA; Rance B; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Pasmant E; Batteux F; Borghese B; Alexandre J; Leroy K
    PLoS One; 2019; 14(3):e0214416. PubMed ID: 30908539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function.
    Takahashi J; Suzuki T; Sato M; Nitta S; Yaguchi N; Muta T; Tsuchida K; Suda H; Morita M; Hamada S; Masamune A; Takahashi S; Kamei T; Yamamoto M
    Cell Rep; 2024 Apr; 43(4):114104. PubMed ID: 38602872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.